Status:
COMPLETED
Cognitive Behavioral Factors and Central Sensitization in Chronic Shoulder Pain
Lead Sponsor:
Technological Education Institute of Sterea Ellada
Collaborating Sponsors:
KAT General Hospital
Vrije Universiteit Brussel
Conditions:
Chronic Shoulder Pain
Eligibility:
All Genders
18-80 years
Brief Summary
The objective of this study is to examine the relationship between symptoms of central sensitization (CS) and important cognitive behavioral and psychosocial factors in patients with chronic shoulder ...
Detailed Description
Participants, both male and female, with chronic shoulder pain for at least 3 months will be included in the study. They will complete several questionnaires and a functional test. Spearman's correlat...
Eligibility Criteria
Inclusion
- (1)chronic unilateral shoulder pain (Chronic pain will be defined as pain lasting for 3 or more months. Also, pain intensity will be at least 3 on a 0-10 numerical pain rating scale on most days of the last 3 months).
Exclusion
- recent shoulder dislocation (1 year prior) and/or systemic diseases such as rheumatoid arthritis, fibromyalgia and/or polymyalgia rheumatic
- shoulder pain considered to be originated from the cervical region, and other traumas,
- neurological dysfunction (ie, multiple sclerosis or stroke), osteoporosis, haemophilia and/or cancer
- shoulder surgery
- participants with shoulder pain after post fracture
- Being pregnant or given birth in the preceding year
- Overconsumption of alcohol or any other recreational drug2
- Cognitive impairment
- inability to provide informed consent and/or complete written questionnaires
- If participants use medication with a known influence on the central nervous system (eg, anti-epileptic and antidepressant, analgesics, and/or NSAID's), it should be stable in medication intake for at least 1 month prior to his/her participation to be included in this study (Kuppers et al. 2017). Patients are required to continue usual care at least 6 weeks prior to study participation to obtain a steady state.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 25 2019
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03838471
Start Date
December 1 2018
End Date
March 25 2019
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KAT Hospital
Athens, Greece